S
LIVE

Serial Number

99154994

Owner

SpyGlass Pharma, Inc.

Attorney

Hillary E. Maynard

First Use Date

May 1, 2021

Filing Date

Apr 25, 2025

Add to watchlist:

No watchlists yet
View on USPTO

S Trademark

Serial Number: 99154994

S is a trademark filed by SpyGlass Pharma, Inc. on April 25, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

SpyGlass Pharma, Inc.

27061 Aliso Creek Rd.
Aliso Viejo, CA 92656

Entity Type: 03

Trademark Details

Filing Date

April 25, 2025

Registration Date

Not Registered

First Use Anywhere

May 1, 2021

First Use in Commerce

May 1, 2021

Published for Opposition

February 17, 2026

Goods & Services

Providing medical and scientific information and analysis in the field of ophthalmic-related health conditions and treatment, reducing onset of, and/or prevention thereof; Providing medical and scientific research information in the field of ophthalmic-related health conditions and treatment, reducing onset of, and/or prevention thereof

Intraocular implants, namely, intraocular lenses and intraocular implant platforms for receiving pharmaceutical preparations; drug delivery devices sold empty for use in conjunction with intraocular lenses and lens stability rings, namely, an acrylic intraocular lens platform equipped for receiving pads; Intraocular implants being lenses; drug delivery devices sold empty for use in conjunction with intraocular implants, namely, an acrylic intraocular lens platform equipped for receiving pads

Scientific and technological services, namely, scientific research, analysis and design of products and technology in the fields of ophthalmic-related health conditions and short-term, intermittent and/or sustained intraocular drug delivery; Product development of technology for the treatment, reducing onset of, and/or prevention of ophthalmic-related health conditions; Research and development services relating to technology for treatment, reducing onset of, and/or prevention of ophthalmic-related health conditions

Implantable drug delivery devices with integrated pharmaceutical preparations for use in conjunction with intraocular lenses and intraocular implant platforms for receiving pharmaceutical preparations to treat eye conditions

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 17, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 17, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 11, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 26, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 16, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 16, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 16, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 18, 2025 GNRN
NON-FINAL ACTION E-MAILED
Sep 18, 2025 GNRT
NON-FINAL ACTION WRITTEN
Sep 18, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 16, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 2, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Apr 25, 2025 MAFR
NEW APPLICATION ENTERED
Apr 25, 2025 NWAP